1.48
60 Degrees Pharmaceuticals Inc stock is traded at $1.48, with a volume of 52,505.
It is down -3.90% in the last 24 hours and up +4.96% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.54
Open:
$1.49
24h Volume:
52,505
Relative Volume:
0.10
Market Cap:
$6.07M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.1484
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
+6.47%
1M Performance:
+4.96%
6M Performance:
-19.57%
1Y Performance:
-76.32%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SXTP
60 Degrees Pharmaceuticals Inc
|
1.48 | 6.32M | 502.40K | -7.91M | -4.32M | -9.972 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
Will 60 Degrees Pharmaceuticals Inc. rebound enough to break evenJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
What does recent volatility data suggest for 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com
Using Python tools to backtest 60 Degrees Pharmaceuticals Inc. strategiesTrade Entry Report & AI Enhanced Trading Alerts - newser.com
Real time breakdown of 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performanceJuly 2025 Opening Moves & Community Driven Trade Alerts - newser.com
How buybacks impact 60 Degrees Pharmaceuticals Inc. stock valueWeekly Market Report & Daily Technical Forecast Reports - newser.com
Sector ETF performance correlation with 60 Degrees Pharmaceuticals Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com
Why retail investors pile into 60 Degrees Pharmaceuticals Inc. stockJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
Is now a turning point for 60 Degrees Pharmaceuticals Inc. Equity WarrantWeekly Trade Report & Safe Capital Growth Plans - newser.com
What Fibonacci levels say about 60 Degrees Pharmaceuticals Inc. Equity Warrant reboundJuly 2025 Final Week & Real-Time Volume Spike Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock gaining market shareWeekly Market Summary & Target Return Focused Stock Picks - newser.com
Using RSI to spot recovery in 60 Degrees Pharmaceuticals Inc.Quarterly Trade Review & Long-Term Safe Investment Ideas - newser.com
Analyzing recovery setups for 60 Degrees Pharmaceuticals Inc. investorsRate Cut & Fast Entry High Yield Tips - newser.com
Is this a good reentry point in 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Earnings Surprises & Community Consensus Trade Alerts - newser.com
Analyzing Aurinia Pharmaceuticals (NASDAQ:AUPH) & 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
What candlestick patterns are forming on 60 Degrees Pharmaceuticals Inc.July 2025 Retail & Daily Chart Pattern Signals - newser.com
Tools to assess 60 Degrees Pharmaceuticals Inc. Equity Warrant’s risk profile2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
What MACD and RSI say about 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Patterns & Free Community Consensus Stock Picks - newser.com
News impact scoring models applied to 60 Degrees Pharmaceuticals Inc. Equity WarrantGold Moves & AI Enhanced Trading Signals - newser.com
Risk adjusted return profile for 60 Degrees Pharmaceuticals Inc. analyzedJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
Earnings visualization tools for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
Volume spikes in 60 Degrees Pharmaceuticals Inc. stock – what they meanWeekly Profit Summary & Verified Entry Point Signals - newser.com
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):